High melanoma risk in non-melanoma skin cancer patients under age 40: a large retrospective cohort study

被引:0
|
作者
Ricci, Francesco [1 ]
Paradisi, Andrea [2 ]
Fania, Luca [3 ]
Pallotta, Sabatino [4 ]
Di Lella, Giovanni [5 ]
Sobrino, Luciano [6 ]
Panebianco, Annarita [7 ]
Abeni, Damiano [8 ]
机构
[1] IDI IRCCS, Unit Melanoma, Via Monti Creta 104, I-00167 Rome, Italy
[2] Cristo Re Gen Hosp, Unit Dermatol, Rome, Italy
[3] Ist Dermopat Immacolata IDI IRCCS, Dermatol Clin 1, Rome, Italy
[4] Ist Dermopat Immacolata IDI IRCCS, Dermatol Clin 5, Rome, Italy
[5] Ist Dermopat Immacolata IDI IRCCS, Unit Day Surg, Rome, Italy
[6] Ist Dermopat Immacolata IDI IRCCS, Hosp Informat Syst, Rome, Italy
[7] Ist Dermopat Immacolata IDI IRCCS, Rome, Italy
[8] IDI IRCCS, Unit Clin Epidemiol, Rome, Italy
关键词
Melanoma; Skin neoplasms; Risk; SUBSEQUENT CUTANEOUS MALIGNANCY; VARIANTS;
D O I
10.23736/S2784-8671.19.06276-X
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
BACKGROUND: Patients with a history of non-melanoma skin cancer (NMSC) are at increased risk for other primary cancers, in particular for cutaneous melanoma. However, rarely such studies are able to identify age-specific risks due to the lack of statistical power. The aim of this study was to compare the risk of melanoma development within age groups in a large cohort of NMSC patients and in a control group of non-dermatological patients. METHODS: A retrospective linkage analysis was performed between records of hospitalizations and the occurrence of melanoma was compared within 10-year age group by computing the relative risk (RR) and modeled using multiple logistic regression. RESULTS: The linkage procedures identified 30,929 individuals with NMSC and 25,956 control patients. Overall, NMSC patients had RR for melanoma of 6.2 compared to controls. Patients with NMSC and less than 40 years of age have a RR of melanoma of 25.1 compared to controls. Our study is a retrospective analysis, and our ICD-9 codes do not distinguish between basal cell carcinoma and squamous cell carcinoma, nor between subtypes of melanoma. CONCLUSIONS: Our large study suggests that prevention of melanoma in NMSC patients is mandatory, especially for patients which develop a NMSC under 40 years of age.
引用
收藏
页码:240 / 243
页数:4
相关论文
共 50 条
  • [31] Heterogeneity in Host Risk Factors for Incident Melanoma and Non-Melanoma Skin Cancer in a Cohort of US Women
    Qureshi, Abrar A.
    Zhang, Mingfeng
    Han, Jiali
    JOURNAL OF EPIDEMIOLOGY, 2011, 21 (03) : 197 - 203
  • [32] Risk of subsequent non-melanoma skin cancer in a cohort of patients with primary basal cell carcinoma
    Revenga, F
    Paricio, JF
    Vázquez, MM
    del Villar, V
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2004, 18 (04) : 514 - 515
  • [33] Risk of non-melanoma skin cancer in a national cohort of veterans with rheumatoid arthritis
    Amari, Wassila
    Zeringue, Angelique L.
    McDonald, Jay R.
    Caplan, Liron
    Eisen, Seth A.
    Ranganathan, Prabha
    RHEUMATOLOGY, 2011, 50 (08) : 1431 - 1439
  • [34] High-risk non-melanoma skin cancer of the head and neck
    Lai S.Y.
    Weber R.S.
    Current Oncology Reports, 2005, 7 (2) : 154 - 158
  • [35] Systemic Retinonds for Chemoprevendon of Non-melanoma Skin Cancer in High-risk Patients
    Marquez, Christina
    Bair, Sarah M.
    Smithberger, Erica
    Cherpelis, Basil S.
    Fenske, Neil Alan
    Glass, L. Frank
    JOURNAL OF DRUGS IN DERMATOLOGY, 2010, 9 (07) : 753 - 758
  • [36] Prediction of the Occurrence of Melanoma and Non-melanoma Skin Cancer in Patients with Vitiligo
    Hammoud, Shedia M.
    Kruis, Rosalie W. J.
    Sigurdsson, Vigfus
    ACTA DERMATO-VENEREOLOGICA, 2016, 96 (01) : 106 - 107
  • [37] Melanoma and Non-Melanoma Skin Cancer in Patients with Chronic Lymphocytic Leukemia
    Call, Timothy G.
    Rabe, Kari G.
    Jerry, Brewer D.
    Kay, Neil E.
    Zent, Clive S.
    Schwager, Susan M.
    Bowen, Deborah A.
    Leis, Jose F.
    Tun, Han
    Markovic, Svetomir N.
    Slager, Susan L.
    Shanafelt, Tait D.
    BLOOD, 2009, 114 (22) : 521 - 522
  • [38] Risk of non-melanoma skin cancer in myasthenia patients treated with azathioprine
    Pedersen, E. G.
    Pottegard, A.
    Hallas, J.
    Friis, S.
    Hansen, K.
    Jensen, P. E. H.
    Gaist, D.
    EUROPEAN JOURNAL OF NEUROLOGY, 2014, 21 (03) : 454 - 458
  • [39] INTEREST IN PERSONALIZED GENOMIC TESTING FOR MELANOMA RISK AMONG NON-MELANOMA SKIN CANCER PATIENTS
    Christian, Stephanie N.
    Watsula-Morley, Amanda
    Lee, Erica H.
    Zhang, Liying
    Sadeghi, Keimya
    Leong, Siok
    Li, Yuelin
    Schofield, Elizabeth A.
    Robson, Mark E.
    Hamilton, Jada G.
    Halpern, Allan C.
    Orlow, Irene
    Hay, Jennifer L.
    ANNALS OF BEHAVIORAL MEDICINE, 2019, 53 : S270 - S270
  • [40] Risk of Non-melanoma Skin Cancer in Autoimmune Hepatitis
    Leung, John
    Dowling, Lauren
    Obadan, Isi
    Davis, James
    Bonis, Peter A.
    Kaplan, Marshall M.
    Casey, Darlene
    Viveiros, Kathleen
    DIGESTIVE DISEASES AND SCIENCES, 2010, 55 (11) : 3218 - 3223